| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 5488- | EP, | An in vivo study of a custom-made high-frequency irreversible electroporation generator on different tissues for clinically relevant ablation zones |
| - | in-vivo, | Nor, | NA |
| 5519- | EP, | Nanosecond Pulsed Electric Fields (nsPEFs) for Precision Intracellular Oncotherapy: Recent Advances and Emerging Directions |
| - | Review, | Var, | NA |
| 5522- | EP, | Nanosecond pulsed electric field suppresses growth and reduces multi-drug resistance effect in pancreatic cancer |
| - | in-vitro, | PC, | NA |
| 5523- | EP, | Nanosecond pulsed electric field applications rejuvenate aging endothelial cells by rescuing mitochondrial-to-nuclear retrograde communication |
| - | vitro+vivo, | Nor, | HUVECs |
| 6790- | EPA, | Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia |
| - | Trial, | Lung, | NA |
| - | vitro+vivo, | Var, | NA |
| 6792- | EPA, | Effect of Eicosapentaenoic Acid on Body Composition and Inflammation Markers in Patients with Head and Neck Squamous Cell Cancer from a Public Hospital in Mexico |
| - | Trial, | HNSCC, | NA |
| 6425- | ESTr, | Assessing the Risk of Estragole Consumption From Natural Products in the Malaysian Market by Using the Margin of Exposure Approach |
| - | Review, | Nor, | NA |
| 6577- | EU, | Eurycomanone suppresses expression of lung cancer cell tumor markers, prohibitin, annexin 1 and endoplasmic reticulum protein 28 |
| - | in-vitro, | Lung, | A549 |
| 6578- | EU, | Eurycomanol and eurycomanone as potent inducers for cell-cycle arrest and apoptosis in small and large human lung cancer cell lines |
| - | in-vitro, | Lung, | H460 | - | in-vitro, | Lung, | A549 |
| 6585- | EU, | Anti-Tumor Activity of Eurycoma longifolia Root Extracts against K-562 Cell Line: In Vitro and In Vivo Study |
| - | vitro+vivo, | AML, | K562 |
| 6391- | Eug, | BCP, | 5-FU, | Exploring Mechanism of Actions for Eugenol and Beta-Caryophyllene to Combat Colorectal Cancer Chemotherapy Using Network Pharmacology |
| - | in-vitro, | CRC, | HCT116 |
| 6379- | Eug, | Safety assessment of a standardized polyphenolic extract of clove buds: Subchronic toxicity and mutagenicity studies |
| - | in-vivo, | Nor, | NA |
| 6376- | Eug, | Preparation, characterization, oral bioavailability, and pharmacodynamic study of eugenol-porous silica solidified powder |
| - | NA, | Nor, | NA |
| 6388- | Eug, | Eugenol’s anti-cancer properties, its modulation of signalling pathways, and cascades across various cancers: A review |
| - | Review, | Var, | NA |
| 6846- | EVO, | Evodiamine Inhibits Colorectal Cancer Growth via RTKs Mediated PI3K/AKT/p53 Signaling Pathway |
| - | in-vitro, | CRC, | HT29 | - | in-vitro, | CRC, | HCT116 |
| 6837- | EVO, | Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity |
| - | in-vitro, | BC, | MCF7 |
| 5230- | Ex, | Effects of an acute maximal exercise bout on serum insulin-like growth factor-1 in adults with MDD |
| - | Trial, | Nor, | NA |
| 2143- | Ex, | The association between physical activity and bladder cancer: systematic review and meta-analysis |
| - | Review, | Bladder, | NA |
| 2144- | Ex, | Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies |
| - | Analysis, | NA, | NA |
| 2145- | Ex, | Leisure time physical activity and cancer risk: evaluation of the WHO's recommendation based on 126 high-quality epidemiological studies |
| - | Analysis, | Var, | NA |
| 2150- | Ex, | Roles and molecular mechanisms of physical exercise in cancer prevention and treatment |
| - | Review, | Var, | NA |
| 2149- | Ex, | Physical activity and exercise training in cancer patients |
| - | Analysis, | Var, | NA |
| 4075- | FA, | Folic acid, ageing, depression, and dementia |
| - | Review, | AD, | NA |
| 3714- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review |
| - | Review, | AD, | NA |
| 6870- | FA, | Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 6866- | FA, | Ang, | Effects of Ferulic Acid and Angelica archangelica Extract (Feru-guard ®) on Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Prospective Trial |
| - | Trial, | AD, | NA |
| 6863- | FA, | HCAs, | Absorption of hydroxycinnamates in humans after high-bran cereal consumption |
| - | Human, | Nor, | NA |
| 6882- | FA, | Short- and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats |
| - | in-vivo, | Nor, | NA |
| 6885- | FA, | Mitigation of renal toxicity induced by paraquat using ferulic acid: Role of inflammatory pathways |
| - | in-vivo, | Nor, | NA |
| 6883- | FA, | Ang, | Effect of ferulic acid and Angelica archangelica extract on behavioral and psychological symptoms of dementia in frontotemporal lobar degeneration and dementia with Lewy bodies |
| - | Trial, | AD, | NA |
| 6952- | FA, | Knowledge gaps in understanding the metabolic and clinical effects of excess folates/folic acid: a summary, and perspectives, from an NIH workshop |
| - | Review, | AD, | NA |
| 6951- | FA, | Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI |
| - | Trial, | AD, | NA |
| - | Trial, | AD, | NA |
| 6948- | FA, | VitB12, | A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people |
| - | Trial, | AD, | NA |
| 6953- | FA, | Folic Acid Supplementation and Risk of Gestational Diabetes Mellitus: A Systematic Review of the Literature |
| - | Review, | Diabetic, | NA |
| 6955- | FA, | Women Taking a Folic Acid Supplement in Countries with Mandatory Food Fortification Programs May Be Exceeding the Upper Tolerable Limit of Folic Acid: A Systematic Review |
| - | Review, | Nor, | NA |
| 6956- | FA, | VitB12, | A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients |
| - | Trial, | AD, | NA |
| 6961- | FA, | VitB12, | VitB6, | Silicon, | Alum | B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment |
| - | Trial, | AD, | NA |
| 7507- | FA, | Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 |
| 7829- | FA, | MBS, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA |
| 6862- | FBZ, | Research: The Urgent Need for Clinical Studies to Evaluate the Anti-Tumor Efficacy of Fenbendazole |
| - | Review, | Var, | NA |
| 6849- | FBZ, | Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients |
| - | Case Report, | BC, | NA | - | Case Report, | Pca, | NA | - | Case Report, | Melanoma, | NA |
| 6850- | FBZ, | Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information |
| - | Case Report, | Lung, | NA |
| 6851- | FBZ, | Severe Drug-Induced Liver Injury Due to Self-administration of the Veterinary Anthelmintic Medication, Fenbendazole |
| - | Case Report, | Var, | NA |
| 6852- | FBZ, | Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report |
| - | Case Report, | Colon, | NA |
| 6853- | FBZ, | Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 6860- | FBZ, | IVM, | Drug-Induced Liver Injury Following Co-ingestion of Veterinary Fenbendazole and Ivermectin for Prostate Cancer: A Case Report |
| - | Case Report, | Pca, | NA |
| 2497- | FBZ, | In vitro anti-tubulin effects of mebendazole and fenbendazole on canine glioma cells |
| - | in-vitro, | GBM, | NA |
| 6430- | FEO, | Foeniculum vulgare: A comprehensive review of its traditional use, phytochemistry, pharmacology, and safety |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid